Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongfu Liu

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Journal of Medicinal Chemistry|October 20, 2018
Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion InhibitorsXiufang Zheng, Chungen Liang, Lisha Wang, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Discovery of Potent and Efficacious Influenza PB2 InhibitorsJun Wu, Yongfu Liu, Dongbo Li, et al.
Journal of Medicinal Chemistry|June 14, 2019
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein InhibitorXiufang Zheng, Lu Gao, Lisha Wang, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus InfectionDongdong Chen, Xuefei Tan, Wenming Chen, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Medicinal Chemistry|October 20, 2018
Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion InhibitorsXiufang Zheng, Chungen Liang, Lisha Wang, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
Discovery of Potent and Efficacious Influenza PB2 InhibitorsJun Wu, Yongfu Liu, Dongbo Li, et al.
Journal of Medicinal Chemistry|June 14, 2019
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein InhibitorXiufang Zheng, Lu Gao, Lisha Wang, et al.
Journal of Medicinal Chemistry|August 16, 2022
Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus InfectionDongdong Chen, Xuefei Tan, Wenming Chen, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Pageof 5